Related Experiment Videos
Chronic myelogenous leukemia: is aggressive treatment indicated?
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Fibronectin adsorption studied using neutron reflectometry and complementary techniques.
The European physical journal. E, Soft matter·2009
Synthesis of a potentially bioactive, hydroxyapatite-nucleating molecule.
Calcified tissue international·2006
p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl).
The Journal of experimental medicine·2001
Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Contemporary Management of Relapsed or Refractory Chronic Lymphocytic Leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Longitudinal Change in Cardiac Function After Doxorubicin and Dexrazoxane: A Report From Children's Oncology Group ALTE11C2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Darolutamide Alone and in Combination With Goserelin in Androgen Receptor-Positive Salivary Gland Carcinoma: Results From the Phase II DISCOVARY Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026